PT95970A - Processo de preparacao e acidos carboxilicos aza-heterociclicos substituidos em n e de composicoes farmaceuticas - Google Patents

Processo de preparacao e acidos carboxilicos aza-heterociclicos substituidos em n e de composicoes farmaceuticas

Info

Publication number
PT95970A
PT95970A PT95970A PT9597090A PT95970A PT 95970 A PT95970 A PT 95970A PT 95970 A PT95970 A PT 95970A PT 9597090 A PT9597090 A PT 9597090A PT 95970 A PT95970 A PT 95970A
Authority
PT
Portugal
Prior art keywords
carboxylic acids
image
azo
pharmaceutical compositions
preparation process
Prior art date
Application number
PT95970A
Other languages
English (en)
Other versions
PT95970B (pt
Inventor
Knud Erik Andersen
Lars Jacobs Stray Knudsen
Ursula Sonnewald
Per Olaf Sorensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PT95970A publication Critical patent/PT95970A/pt
Publication of PT95970B publication Critical patent/PT95970B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
PT95970A 1989-11-22 1990-11-22 Processo de preparacao e acidos carboxilicos aza-heterociclicos substituidos em n e de composicoes farmaceuticas PT95970B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK588189A DK588189D0 (da) 1989-11-22 1989-11-22 Nye heterocykliske carboxylsyrer

Publications (2)

Publication Number Publication Date
PT95970A true PT95970A (pt) 1991-09-13
PT95970B PT95970B (pt) 1998-01-30

Family

ID=8145900

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95970A PT95970B (pt) 1989-11-22 1990-11-22 Processo de preparacao e acidos carboxilicos aza-heterociclicos substituidos em n e de composicoes farmaceuticas

Country Status (16)

Country Link
US (1) US5198451A (pt)
EP (1) EP0502031B1 (pt)
JP (1) JPH05503083A (pt)
AT (1) ATE157086T1 (pt)
AU (1) AU660919B2 (pt)
CA (1) CA2073189C (pt)
DE (1) DE69031312T2 (pt)
DK (2) DK588189D0 (pt)
FI (1) FI97541C (pt)
IE (1) IE904155A1 (pt)
IL (2) IL96370A (pt)
NO (1) NO177853C (pt)
NZ (1) NZ236155A (pt)
PT (1) PT95970B (pt)
WO (1) WO1991007389A1 (pt)
ZA (1) ZA909305B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
ES2297859T3 (es) * 1996-05-24 2008-05-01 Smithkline Beecham Corporation Uso de inhibidores de la captacion de gaba como agentes antitusivos.
DE10204496A1 (de) * 2002-02-04 2003-08-21 Msa Auer Gmbh Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US4772615A (en) * 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
DE3787657T2 (de) * 1986-01-07 1994-02-03 Novo Ind A S Bagsvaerd Aminosäure-Derivate.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
NO921852L (no) 1992-05-11
FI97541B (fi) 1996-09-30
DE69031312D1 (de) 1997-09-25
NZ236155A (en) 1993-04-28
ATE157086T1 (de) 1997-09-15
IL96370A (en) 1995-01-24
EP0502031A1 (en) 1992-09-09
DK0502031T3 (da) 1998-03-30
AU6746490A (en) 1991-06-13
US5198451A (en) 1993-03-30
ZA909305B (en) 1991-09-25
FI97541C (fi) 1997-01-10
CA2073189A1 (en) 1991-05-23
DK588189D0 (da) 1989-11-22
AU660919B2 (en) 1995-07-13
FI922268A0 (fi) 1992-05-19
FI922268A (fi) 1992-05-19
CA2073189C (en) 1998-04-07
NO177853B (no) 1995-08-28
PT95970B (pt) 1998-01-30
WO1991007389A1 (en) 1991-05-30
NO921852D0 (no) 1992-05-11
NO177853C (no) 1995-12-06
IE904155A1 (en) 1991-05-22
IL96370A0 (en) 1991-08-16
JPH05503083A (ja) 1993-05-27
EP0502031B1 (en) 1997-08-20
DE69031312T2 (de) 1998-02-26

Similar Documents

Publication Publication Date Title
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
ATE163012T1 (de) N-substituierte 4-pyrimidinamine und - pyrimidindiamine, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel
CZ332599A3 (cs) Cyklické deriváty amidů acylaminokyselin substituované thioskupinou a způsob jejich přípravy
MX9707531A (es) Nuevos compuestos heterociclicos.
PT849269E (pt) Vinil-pirrolidina cefalosporinas com substituintes basicos
HUT64842A (en) Method for producing pharmaceutical preparatives containing 2-[n-(2-amino-ethyl)-amino]-acetic acid derivatives
DK390587A (da) 7-oeoe3-aminomethyl-3-alkylaa-1-pyrrolidinylaa-quino lin-carboxylsyre
HUT57773A (en) Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds
KR870004955A (ko) 다양한 n-치환된 3-피페리딘카복실산 또는 n-치환된 3-피리딘카복실산 및 당해 유도체
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
AR008255A1 (es) Procedimiento para sintetizar antibioticos de carbapenem
PT95970A (pt) Processo de preparacao e acidos carboxilicos aza-heterociclicos substituidos em n e de composicoes farmaceuticas
HUT67695A (en) 4-[(2-benzothiazolyl)-methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperedineethanol, pharmaceutical compositions containing that and process for preparing them
RU93053624A (ru) 4-[(2-БЕНЗОТИАЗОЛИЛ)МЕТИЛАМИНО] -α- [(3,4-ДИФТОРОФЕНОКСИ)МЕТИЛ]-1-ПИПЕРИДИНЭТАНОЛ, СПОСОБ ЕГО ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
DE3863214D1 (de) Glutaminsaeurederivate, ihre salze, verfahren zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zusammensetzungen.
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
RU93046412A (ru) N-ПРОИЗВОДНЫЕ (ФЕНИЛЭТИЛ- β -ОЛ)АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
GR3021200T3 (en) (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them.
DE50000905D1 (de) Verfahren zur Herstellung von N-Acyl-aminosäureestern und N-Acyl-aminoacetalen

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910408

FG3A Patent granted, date of granting

Effective date: 19971020